Clicky

Cannabis

Kratom Gummies vs Capsules: Ingredients, Labels and Side Effects

Gummies and capsules can both be sold as kratom, but the form says little about what's inside, so this guide shows you what to check on the label before you choose.

Short answer: a kratom gummy and a kratom capsule are not interchangeable milligram for milligram, and the form on its own tells you very little about what’s inside. Kratom is not FDA approved for any use, and the FDA’s kratom page says kratom is not lawfully marketed in the U.S. as a drug product, a dietary supplement, or a food additive. The label, the ingredient list and a lab report for the batch you’re buying are where the real comparison happens, so that’s what this page walks you through.

What is a kratom gummy?

Kratom is a tropical tree, Mitragyna speciosa, native to Southeast Asia. The CDC poison-center report describes the U.S. market as “a rapidly expanding commercial market of powders, tablets, gummies, and concentrated energy shots.” A gummy is the chewable version. What it holds varies by product, so the label is where you find out whether it lists leaf powder, an extract, or something else.

Kratom gummy vs capsule: what actually differs?

A capsule is usually powdered kratom inside a shell. The DEA kratom profile lists “encapsulated powder” among the forms sold online. One seller, Occurs Naturally, says its capsules are made of gelatin or vegetable-based casing, which matters if you avoid animal gelatin. For gummies, the contents differ from product to product, so you compare them on the label rather than on the form.

Feature Capsule Gummy
What it usually holds Kratom powder (“encapsulated powder,” per the DEA profile) Varies by product. Confirm on the label.
Shell or base Gelatin or vegetable-based casing (Occurs Naturally) Varies by product
Taste Usually tasteless, according to seller pages Varies by product
Amount per piece Pre-filled. Kona Kratom says underfilled capsules can give an inaccurate dosage. Varies by product
Studied in the trials below Yes. A 2026 trial used capsules of dried leaf powder. None of the trials below tested a gummy.

Why the milligram number doesn’t carry across forms

It’s tempting to read the number on a gummy and the number on a capsule as the same thing. They aren’t the same thing. Kona Kratom says powder and capsules hold the same material and can give the same potency when dosed equally. That’s the seller’s own claim, not a finding from the studies below. The 2026 extract study is a different matter. It reports that concentrated kratom extracts “may yield greater overall mitragynine exposure than dried kratom leaf powder or kratom tea preparations administered at comparable doses.” An extract and a leaf product are not the same thing, even at the same listed amount.

Is there a difference in kratom products?

Yes, and the differences matter more than the shape of the package. The FDA notes that kratom contains over 50 alkaloids, and most research focuses on mitragynine and 7-hydroxymitragynine (7-OH). The DEA puts mitragynine at about 66% of total alkaloid content and 7-OH at under 2%. It also says the alkaloid content “varies significantly based on factors like plant strain and maturity.” A color name like red, green or white doesn’t tell you the alkaloid makeup.

Leaf products, extracts and 7-OH products are different things. Leaf is the dried, ground plant. An extract is concentrated. 7-OH is a minor leaf alkaloid, and the FDA says it has “substantially greater mu-opioid receptor potency” than mitragynine and morphine. That is a receptor finding, not a finding about what people experience. The CDC describes high-potency 7-OH products as “distinct from traditional kratom leaf preparations.” This page covers leaf products and extracts. It does not recommend 7-OH products.

What should you check on the label before you buy?

These are the things a buyer can check. None of them makes a product better by itself, but together they tell you what you’re getting.

  • Ingredient list. Does it name leaf powder, an extract, or 7-OH? The product name or a color name isn’t enough.
  • A lab report for the lot. Ask for the report for the batch number on your package. One seller’s blog lists third-party lab testing for heavy metals as part of what a good vendor does.
  • Warnings and age limits. Read them on the package. The FDA’s 7-OH page asks readers who have a bad reaction to let the FDA know through its MedWatch program.
  • Amount per piece. See how much is in each capsule or gummy, and how many come in the container.
  • Capsule shell. Gelatin or vegetable-based, if that matters to you.
  • Written return terms. Find them on the seller’s site before you pay.

Flavor and chewable form are part of the label question too. The Federal Register notice of October 14, 2026 says flavored chewable 7-OH products “increases their appeal to a broader demographic.” That concern is about 7-OH products, but it’s a reason to read age limits and warnings on any kratom product.

The DEA also notes that kratom products “have not been subjected to regulatory scrutiny that comes with prescription drugs, dietary supplements, or food additives.” That’s why the label checks above matter.

What do the studies show?

The human studies are small, mostly about leaf powder or extract, and none of them tested a gummy. Two 2026 write-ups report the same numbers of participants, 116 in total (49 kratom and 67 placebo), but describe the study material differently. One calls it dried kratom leaf powder, and the other calls it kratom capsules containing dried leaf powder. A form label can blur what was actually tested.

Study Who took part Material Length What it found
2026 powder safety trial (Therapeutic Drug Monitoring) 116 healthy volunteers, aged 18 to 55, randomized, double-blind, placebo-controlled MitraLeaf dried kratom leaf powder 47 days: escalating single doses, then 15 daily doses No serious adverse events or deaths. Most common after single doses: dizziness, nausea, feeling of relaxation. After daily doses: headache, feeling hot, increased alanine aminotransferase level, nausea. The authors concluded the powder was “safe and well tolerated at the dose ranges tested.”
2026 abuse-potential study (Drug Testing and Analysis) 116 healthy, kratom-naive adults (49 kratom, 67 placebo) Mitra-Leaf kratom capsules containing dried leaf powder Single dose or 15 consecutive daily doses Subjective effects were dose-related and decreased after repeated dosing. No participants met the threshold for clinically meaningful opioid withdrawal. Adverse events were more frequent at higher doses and generally mild. The authors stress “the importance of dose control and product standardization.”
Pilot dose-finding study (Journal of Clinical Psychopharmacology) 40 recreational polydrug users with opioid experience Botanical kratom (leaf) with trace 7-OH Single dose, with escalating dose levels No deaths or serious adverse events. Most common: somnolence, vomiting, nausea. At the highest dose, increases in “drug liking,” good effects, and “high” ratings. The authors note the results “may not be representative of other kratom-containing products.”
Kratom drug interaction study 12 healthy adults A single low dose of kratom tea Single dose Kratom showed no change in dextromethorphan levels and a modest increase in midazolam exposure. The authors say “co-consuming kratom with certain drugs extensively metabolized by CYP3A may precipitate serious interactions.”
Kratom extract study (2026) Human volunteers Concentrated kratom extract, 39.5% mitragynine Single doses and 15 daily doses Concentrated extracts “may yield greater overall mitragynine exposure than dried kratom leaf powder or kratom tea preparations administered at comparable doses.” The paper states all authors are consultants to NP Pharma, LLC and were compensated for writing the manuscript.

For a wider look at the research, see kratom benefits evidence (our research library). The NCCIH’s overall verdict is that “very little research in people has evaluated the health effects of kratom.”

What are the side effects?

The NCCIH lists mild effects as nausea, constipation, dizziness, and drowsiness, and rare but serious effects as seizures, high blood pressure, and liver problems. The DEA adds itching, sweating, dry mouth, increased urination, and loss of appetite as acute effects. The table below groups what sources report.

Effect Where it’s reported
Nausea, constipation, dizziness, drowsiness NCCIH, as mild effects
Nausea, vomiting, constipation, sedation FDA, as classic opioid-related effects
Itching, sweating, dry mouth, increased urination, loss of appetite DEA, as acute side effects
Seizures, high blood pressure, liver problems NCCIH, as rare but serious effects
Liver toxicity, seizures, substance use disorder FDA, as serious adverse events it warns about

What does kratom do to your gut?

The most common gut effects reported are nausea, constipation, and vomiting. The NCCIH lists nausea and constipation among mild effects, the DEA adds loss of appetite, and nausea was among the most common reactions in the 2026 daily-dose trial. If you notice these after taking any form, that’s the same set of effects the sources describe.

How serious are the reported problems?

The NCCIH says “fatal overdoses from kratom alone appear to be extremely rare,” and that the use of kratom with other drugs “has been linked to deaths and severe adverse effects such as liver problems.” The DEA reports that kratom was co-involved in 1,720 cases in the FDA Adverse Event Reporting System from 2008 to 2026, of which 1,585 were serious and 765 involved death. The CDC’s poison-center data show kratom-related reports rising. These are reports, not rates of harm among all users. The super speciosa side effects guide goes further into the list.

What happens if you take kratom daily?

The daily-use data here come from the 2026 trials, which ran 15 daily doses over 47 days. In that trial, the most common reactions after daily dosing were headache, feeling hot, increased alanine aminotransferase level, and nausea. The abuse-potential trial found subjective effects decreased after repeated dosing. The NCCIH warns that “regular kratom users may experience withdrawal symptoms if they stop using it,” and that “the long-term effects of kratom use are not well understood.” If you’re weighing regular use, read the kratom withdrawal guide before you decide.

Does kratom change the way you look?

The DEA profile lists skin darkening, weight loss, and loss of appetite among effects of long-term use, along with insomnia, dry mouth, and frequent urination. These are reported effects of long-term use, and the NCCIH notes that long-term effects are not well understood. No source here describes a change every user will notice.

What is considered heavy kratom use?

The FDA reports that regular users, in several recent studies, self-reported using less than 6 g of botanical kratom per use. That’s what people reported, not a line between light and heavy use. The FDA also says people often use kratom for pain, coughing, diarrhea, anxiety, depression, opioid use disorder, and opioid withdrawal. Those are the uses people report, not uses the research has confirmed.

What should not be taken with kratom?

The CDC says kratom use with alcohol, opioids, benzodiazepines, stimulants, and antidepressants “might increase risk through additive pharmacodynamic effects.” In the CDC poison-center data, multiple-substance reports “accounted for the vast majority of kratom-associated deaths during the study period (184 of 233; 79%).” The FDA says deaths linked to kratom were usually in combination with other drugs, and that kratom’s contribution “is unclear.” The midazolam study in the table above, a single low dose of kratom tea in 12 healthy adults, found a modest increase in midazolam exposure. Midazolam is a drug cleared by CYP3A, which is why the drug list matters. The NCCIH says “more research is needed on drug interactions involving kratom.”

If you take any prescription medicine, talk with your clinician or pharmacist before you use kratom in any form.

Who should talk to a clinician first?

  • Pregnant or breastfeeding. The NCCIH says very little research in people has evaluated kratom’s effects, so ask your clinician before you use it.
  • Taking prescription medicine. The interaction study above is the reason to check with a clinician or pharmacist.
  • Liver disease. The NCCIH and FDA both list liver problems among the serious effects reported.
  • History of substance use. The NCCIH says kratom “may have the potential to be addictive,” and the CDC notes that approximately one third of kratom users in previous studies met criteria for another substance use disorder.

Is kratom legal?

Federally, the FDA says kratom is not lawfully marketed in the U.S. as a drug product, a dietary supplement, or a food additive. The DEA says kratom “remains an unscheduled botanical” under the Controlled Substances Act. The Federal Register document published October 14, 2026 is a notice of intent (a proposed amendment). It covers thresholds for 7-OH and MGPI, and it is not a final rule. State and local rules differ. The FDA says states “may have their own regulations or prohibitions for kratom products” and points readers to state health and law enforcement agencies.

What does it cost?

The only price comparison in this guide is Kona Kratom’s January 7, 2025 comparison, which puts capsules around 25% to 100% above powder depending on the vendor.

Before you order

  • Which form the product is: leaf powder, an extract, or 7-OH, as the ingredient list names it.
  • A lab report for the lot number on your package.
  • The amount in each gummy or capsule, and how many come in the container.
  • Capsule shell: gelatin or vegetable-based.
  • Age limits and warnings printed on the label.
  • Return terms in writing, before checkout.

By HealthDataConsortium.org Research Team

This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.